Oleptro, a new extended-release trazodone for depression

July 2011

You'll see Oleptro, a new extended-release trazodone for depression.

Trazodone is usually given in low doses for sleep. It's not used much for depression because it's so sedating.

Oleptro MIGHT be better tolerated because it provides lower and more constant trazodone levels than the immediate-release version.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Dyslipidemia Lots of patients are asking if they should stop taking niacin (Niaspan, etc) for dyslipidemia
Antiplatelets Brilinta (ticagrelor) will compete with Plavix and Effient
Diabetes Actos might cause bladder cancer
Diabetes how to manage diabetes during fasting
Thyroid Disorders Many older adults get too much levothyroxine (Synthroid, etc)
Antidepressants Oleptro, a new extended-release trazodone for depression
Antidepressants Is it okay to combine an SSRI (fluoxetine, etc) with an SNRI (Effexor XR, Cymbalta)
Respiratory & Allergy Singulair is "as good as" inhaled corticosteroids or long-acting beta-agonists for asthma
Neurology & Pain Abstral (AB-stral) is a new fentanyl sublingual tab for breakthrough pain in cancer patients
Dermatology Verdeso (VER-des-oh) is the first topical corticosteroid FOAM
Infectious Diseases We're running out of antibiotics for multidrug-resistant gram-negative "superbugs"
Statins limiting doses of simvastatin (Zocor, etc)